Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy

Shigeki Ono, Isao Date, Keisuke Onoda, Tomomi Shiota, Takashi Ohmoto, Yoshifumi Ninomiya, Shoji Asari, Ryuichi Morishita

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Subarachnoid hemorrhage (SAH), encephalitis, meningitis, and autoimmune diseases sometimes lead to cerebral angiopathy, characterized specifically by narrowing of vessels, morphological changes in the structure of vessel walls, and a concomitant decrease in cerebral blood flow. Many patients also develop delayed ischemic neurological deficits. Thus, preventing vascular reactions is of paramount importance in treating SAH. Although cerebral vasospasm has some relationship with the inflammatory reaction of major cerebral vessels against the autologous blood, and many trials have attempted to prevent angiopathy after SAH, an effective treatment has not yet been established. The purpose of this article is to evaluate the preventive effect of nuclear factor κB (NF-κB) decoy oligo-DNA after SAH; since NF-κB is closely related to inflammation. In the rabbit angiopathy model after SAH, we evaluated the effectiveness of the decoy oligo-DNA using the angiographic (digital subtraction angiography) and histological (hematoxylin-eosin and Masson's trichrome staining) methods. Moreover, a gel-shift assay for NF-κB was also performed in order to evaluate the activity of NF-κB. We describe a new concept for treating cerebral angiopathy after SAH and for successfully inhibiting cerebral vasospasm and morphological changes in vessel walls in a rabbit model, In this treatment, we used synthetic double-strand oligo-DNA with a high affinity for transcription factor NF-κB, and cationic liposome complex administered through the cerebrospinal fluid.

Original languageEnglish
Pages (from-to)1003-1011
Number of pages9
JournalHuman Gene Therapy
Volume9
Issue number7
Publication statusPublished - May 1 1998

Fingerprint

Subarachnoid Space
Subarachnoid Hemorrhage
Intracranial Vasospasm
DNA
Cerebrovascular Circulation
Rabbits
Digital Subtraction Angiography
Encephalitis
Hematoxylin
Eosine Yellowish-(YS)
Meningitis
Liposomes
Autoimmune Diseases
Blood Vessels
Cerebrospinal Fluid
Transcription Factors
Gels
Staining and Labeling
Inflammation
Therapeutics

ASJC Scopus subject areas

  • Genetics

Cite this

Ono, S., Date, I., Onoda, K., Shiota, T., Ohmoto, T., Ninomiya, Y., ... Morishita, R. (1998). Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy. Human Gene Therapy, 9(7), 1003-1011.

Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy. / Ono, Shigeki; Date, Isao; Onoda, Keisuke; Shiota, Tomomi; Ohmoto, Takashi; Ninomiya, Yoshifumi; Asari, Shoji; Morishita, Ryuichi.

In: Human Gene Therapy, Vol. 9, No. 7, 01.05.1998, p. 1003-1011.

Research output: Contribution to journalArticle

Ono, S, Date, I, Onoda, K, Shiota, T, Ohmoto, T, Ninomiya, Y, Asari, S & Morishita, R 1998, 'Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy', Human Gene Therapy, vol. 9, no. 7, pp. 1003-1011.
Ono S, Date I, Onoda K, Shiota T, Ohmoto T, Ninomiya Y et al. Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy. Human Gene Therapy. 1998 May 1;9(7):1003-1011.
Ono, Shigeki ; Date, Isao ; Onoda, Keisuke ; Shiota, Tomomi ; Ohmoto, Takashi ; Ninomiya, Yoshifumi ; Asari, Shoji ; Morishita, Ryuichi. / Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy. In: Human Gene Therapy. 1998 ; Vol. 9, No. 7. pp. 1003-1011.
@article{bb14ad4bb7864bdc8d88f2a52568a0a7,
title = "Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy",
abstract = "Subarachnoid hemorrhage (SAH), encephalitis, meningitis, and autoimmune diseases sometimes lead to cerebral angiopathy, characterized specifically by narrowing of vessels, morphological changes in the structure of vessel walls, and a concomitant decrease in cerebral blood flow. Many patients also develop delayed ischemic neurological deficits. Thus, preventing vascular reactions is of paramount importance in treating SAH. Although cerebral vasospasm has some relationship with the inflammatory reaction of major cerebral vessels against the autologous blood, and many trials have attempted to prevent angiopathy after SAH, an effective treatment has not yet been established. The purpose of this article is to evaluate the preventive effect of nuclear factor κB (NF-κB) decoy oligo-DNA after SAH; since NF-κB is closely related to inflammation. In the rabbit angiopathy model after SAH, we evaluated the effectiveness of the decoy oligo-DNA using the angiographic (digital subtraction angiography) and histological (hematoxylin-eosin and Masson's trichrome staining) methods. Moreover, a gel-shift assay for NF-κB was also performed in order to evaluate the activity of NF-κB. We describe a new concept for treating cerebral angiopathy after SAH and for successfully inhibiting cerebral vasospasm and morphological changes in vessel walls in a rabbit model, In this treatment, we used synthetic double-strand oligo-DNA with a high affinity for transcription factor NF-κB, and cationic liposome complex administered through the cerebrospinal fluid.",
author = "Shigeki Ono and Isao Date and Keisuke Onoda and Tomomi Shiota and Takashi Ohmoto and Yoshifumi Ninomiya and Shoji Asari and Ryuichi Morishita",
year = "1998",
month = "5",
day = "1",
language = "English",
volume = "9",
pages = "1003--1011",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy

AU - Ono, Shigeki

AU - Date, Isao

AU - Onoda, Keisuke

AU - Shiota, Tomomi

AU - Ohmoto, Takashi

AU - Ninomiya, Yoshifumi

AU - Asari, Shoji

AU - Morishita, Ryuichi

PY - 1998/5/1

Y1 - 1998/5/1

N2 - Subarachnoid hemorrhage (SAH), encephalitis, meningitis, and autoimmune diseases sometimes lead to cerebral angiopathy, characterized specifically by narrowing of vessels, morphological changes in the structure of vessel walls, and a concomitant decrease in cerebral blood flow. Many patients also develop delayed ischemic neurological deficits. Thus, preventing vascular reactions is of paramount importance in treating SAH. Although cerebral vasospasm has some relationship with the inflammatory reaction of major cerebral vessels against the autologous blood, and many trials have attempted to prevent angiopathy after SAH, an effective treatment has not yet been established. The purpose of this article is to evaluate the preventive effect of nuclear factor κB (NF-κB) decoy oligo-DNA after SAH; since NF-κB is closely related to inflammation. In the rabbit angiopathy model after SAH, we evaluated the effectiveness of the decoy oligo-DNA using the angiographic (digital subtraction angiography) and histological (hematoxylin-eosin and Masson's trichrome staining) methods. Moreover, a gel-shift assay for NF-κB was also performed in order to evaluate the activity of NF-κB. We describe a new concept for treating cerebral angiopathy after SAH and for successfully inhibiting cerebral vasospasm and morphological changes in vessel walls in a rabbit model, In this treatment, we used synthetic double-strand oligo-DNA with a high affinity for transcription factor NF-κB, and cationic liposome complex administered through the cerebrospinal fluid.

AB - Subarachnoid hemorrhage (SAH), encephalitis, meningitis, and autoimmune diseases sometimes lead to cerebral angiopathy, characterized specifically by narrowing of vessels, morphological changes in the structure of vessel walls, and a concomitant decrease in cerebral blood flow. Many patients also develop delayed ischemic neurological deficits. Thus, preventing vascular reactions is of paramount importance in treating SAH. Although cerebral vasospasm has some relationship with the inflammatory reaction of major cerebral vessels against the autologous blood, and many trials have attempted to prevent angiopathy after SAH, an effective treatment has not yet been established. The purpose of this article is to evaluate the preventive effect of nuclear factor κB (NF-κB) decoy oligo-DNA after SAH; since NF-κB is closely related to inflammation. In the rabbit angiopathy model after SAH, we evaluated the effectiveness of the decoy oligo-DNA using the angiographic (digital subtraction angiography) and histological (hematoxylin-eosin and Masson's trichrome staining) methods. Moreover, a gel-shift assay for NF-κB was also performed in order to evaluate the activity of NF-κB. We describe a new concept for treating cerebral angiopathy after SAH and for successfully inhibiting cerebral vasospasm and morphological changes in vessel walls in a rabbit model, In this treatment, we used synthetic double-strand oligo-DNA with a high affinity for transcription factor NF-κB, and cationic liposome complex administered through the cerebrospinal fluid.

UR - http://www.scopus.com/inward/record.url?scp=0032078855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032078855&partnerID=8YFLogxK

M3 - Article

C2 - 9607412

AN - SCOPUS:0032078855

VL - 9

SP - 1003

EP - 1011

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 7

ER -